BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30068544)

  • 1. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.
    de Jong SJ; Créquer A; Matos I; Hum D; Gunasekharan V; Lorenzo L; Jabot-Hanin F; Imahorn E; Arias AA; Vahidnezhad H; Youssefian L; Markle JG; Patin E; D'Amico A; Wang CQF; Full F; Ensser A; Leisner TM; Parise LV; Bouaziz M; Maya NP; Cadena XR; Saka B; Saeidian AH; Aghazadeh N; Zeinali S; Itin P; Krueger JG; Laimins L; Abel L; Fuchs E; Uitto J; Franco JL; Burger B; Orth G; Jouanguy E; Casanova JL
    J Exp Med; 2018 Sep; 215(9):2289-2310. PubMed ID: 30068544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV: CIB1 is for EVER and EVER.
    Notarangelo LD
    J Exp Med; 2018 Sep; 215(9):2229-2231. PubMed ID: 30068545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
    Orth G
    Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
    Orth G
    Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the components.
    Wu CJ; Li X; Sommers CL; Kurima K; Huh S; Bugos G; Dong L; Li W; Griffith AJ; Samelson LE
    J Biol Chem; 2020 Nov; 295(47):16086-16099. PubMed ID: 32917726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EVER2 deficiency is associated with mild T-cell abnormalities.
    Crequer A; Picard C; Pedergnana V; Lim A; Zhang SY; Abel L; Majewski S; Casanova JL; Jablonska S; Orth G; Jouanguy E
    J Clin Immunol; 2013 Jan; 33(1):14-21. PubMed ID: 22903682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression is stable in a complete CIB1 knockout keratinocyte model.
    Imahorn E; Aushev M; Herms S; Hoffmann P; Cichon S; Reichelt J; Itin PH; Burger B
    Sci Rep; 2020 Sep; 10(1):14952. PubMed ID: 32917957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole transcriptome-based skin virome profiling in typical epidermodysplasia verruciformis reveals α-, β-, and γ-HPV infections.
    Saeidian AH; Youssefian L; Naji M; Mahmoudi H; Barnada SM; Huang C; Naghipoor K; Hozhabrpour A; Park JS; Manzo Margiotta F; Vahidnezhad F; Saffarian Z; Kamyab-Hesari K; Tolouei M; Faraji N; Azimi SZ; Namdari G; Mansouri P; Casanova JL; Béziat V; Jouanguy E; Uitto J; Vahidnezhad H
    JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36602881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.
    de Jong SJ; Imahorn E; Itin P; Uitto J; Orth G; Jouanguy E; Casanova JL; Burger B
    Front Microbiol; 2018; 9():1222. PubMed ID: 29946305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.
    Horton JS; Stokes AJ
    Oncoimmunology; 2014 Jan; 3(1):e28288. PubMed ID: 24800179
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses.
    Lazarczyk M; Pons C; Mendoza JA; Cassonnet P; Jacob Y; Favre M
    J Exp Med; 2008 Jan; 205(1):35-42. PubMed ID: 18158319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
    McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
    Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.
    Crequer A; Troeger A; Patin E; Ma CS; Picard C; Pedergnana V; Fieschi C; Lim A; Abhyankar A; Gineau L; Mueller-Fleckenstein I; Schmidt M; Taieb A; Krueger J; Abel L; Tangye SG; Orth G; Williams DA; Casanova JL; Jouanguy E
    J Clin Invest; 2012 Sep; 122(9):3239-47. PubMed ID: 22850876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
    Orth G
    Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz.
    Arnold AW; Burger B; Kump E; Rufle A; Tyring SK; Kempf W; Häusermann P; Itin PH
    Dermatology; 2011 Feb; 222(1):81-6. PubMed ID: 21196704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis.
    Zuo YG; Ma D; Zhang Y; Qiao J; Wang B
    J Dermatol Sci; 2006 Dec; 44(3):153-9. PubMed ID: 17008061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
    Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
    Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
    Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
    Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
    Przybyszewska J; Zlotogorski A; Ramot Y
    J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus.
    Frecha C; Chevalier SA; van Uden P; Rubio I; Siouda M; Saidj D; Cohen C; Lomonte P; Accardi R; Tommasino M
    J Virol; 2015 Jan; 89(2):1461-7. PubMed ID: 25378492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.